CRIS Current Research Information System

MALOBERTI, THAIS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.574
EU - Europa 1.739
NA - Nord America 1.241
AF - Africa 203
SA - Sud America 169
OC - Oceania 2
Totale 6.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.205
CN - Cina 1.097
SG - Singapore 908
IT - Italia 895
VN - Vietnam 785
KR - Corea 271
HK - Hong Kong 240
NL - Olanda 165
DE - Germania 150
BR - Brasile 131
IN - India 91
CI - Costa d'Avorio 86
SE - Svezia 78
FI - Finlandia 74
FR - Francia 67
SC - Seychelles 63
GB - Regno Unito 52
IE - Irlanda 46
JP - Giappone 46
RU - Federazione Russa 42
CH - Svizzera 40
ID - Indonesia 30
BG - Bulgaria 24
AT - Austria 22
CA - Canada 21
BD - Bangladesh 19
JO - Giordania 19
PL - Polonia 18
ES - Italia 17
PK - Pakistan 16
AR - Argentina 15
TR - Turchia 15
EC - Ecuador 13
ZA - Sudafrica 13
MK - Macedonia 12
DZ - Algeria 10
MX - Messico 10
TG - Togo 10
CZ - Repubblica Ceca 8
IR - Iran 8
IQ - Iraq 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
NG - Nigeria 5
GR - Grecia 4
RO - Romania 4
TW - Taiwan 4
UG - Uganda 4
VE - Venezuela 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
EE - Estonia 2
EG - Egitto 2
IS - Islanda 2
LB - Libano 2
MQ - Martinica 2
SI - Slovenia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BE - Belgio 1
CO - Colombia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
ML - Mali 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SR - Suriname 1
UZ - Uzbekistan 1
Totale 6.928
Salva come PNG Salva come JPEG
Città #
Singapore 638
Hefei 576
Bologna 340
Ashburn 316
Seoul 270
Ho Chi Minh City 246
Hong Kong 238
Hanoi 210
Abidjan 86
Milan 80
Beijing 77
Dallas 76
Santa Clara 75
Boardman 59
Los Angeles 58
Bengaluru 51
Helsinki 51
Chandler 48
Dublin 44
Tokyo 42
Munich 39
New York 36
Bern 32
Frankfurt am Main 32
Groningen 29
Sofia 24
Turin 23
Rome 22
Da Nang 21
Jakarta 21
Thái Nguyên 20
Amman 19
Florence 19
Ha Long 19
Haiphong 19
Buffalo 18
Pavia 18
Quận Bình Thạnh 17
Redondo Beach 17
Tongling 17
Nuremberg 16
Princeton 16
Vũng Tàu 16
Warsaw 16
Seattle 15
Shanghai 15
Southend 15
Amsterdam 14
Biên Hòa 14
Paris 14
Chicago 13
Hyderabad 13
São Paulo 13
Turku 13
Vienna 12
Atlanta 11
Ninh Bình 11
Redmond 11
Bắc Ninh 10
Falkenstein 10
Hải Dương 10
Lappeenranta 10
Lomé 10
London 10
Rajshahi 10
The Dalles 10
Islamabad 9
Johannesburg 9
Phủ Lý 9
Prilep 9
Quận Một 9
Shenzhen 9
Casalecchio di Reno 8
Guangzhou 8
Houten 8
Lang Son 8
Montreal 8
Naples 8
Rimini 8
San Lazzaro di Savena 8
Stockholm 8
Algiers 7
Berlin 7
Boydton 7
Bắc Giang 7
Can Tho 7
Castel Maggiore 7
Chennai 7
Denver 7
Fairfield 7
Houston 7
Mexico City 7
Pittsburgh 7
Rio de Janeiro 7
Salt Lake City 7
Sherburne 7
Verona 7
Vinh 7
Xi'an 7
Ankara 6
Totale 4.629
Salva come PNG Salva come JPEG
Nome #
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 406
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 317
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 234
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 220
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 217
Next-generation technologies in predictive molecular pathology of lung cancers 194
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 191
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 188
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 184
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 183
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 180
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 169
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 161
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 160
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 159
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 149
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 147
Relevance of ARID1A Mutations in Endometrial Carcinomas 145
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 142
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 140
Analysis of MDM2 and TP53 genes in canine liposarcoma 135
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 132
"Paradoxical" p16 overexpression in cutaneous melanoma: Molecular and immunohistochemical analysis of a rare phenomenon with a focus on cell cycle regulatory molecules 130
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 129
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 128
Morpho-molecular approach (NGS plus digital PCR) in diagnosis of malignant biliary strictures 126
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 122
Integrated clinicopathological and molecular analysis of endometrial carcinoma: prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification 121
Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney 120
Morphologic and molecular diagnostic criteria of malignancies in biliary strictures. 112
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 111
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 106
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 103
Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. 102
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 97
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel 97
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses 96
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 91
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance 90
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 84
Molecular alterations in pancreatic tumors 82
EIF1AX mutations in thyroid nodules: analysis of a series of 1095 consecutive cases. 75
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: Express the role of PIK3CA mutations 73
An exceptional case of primary ovarian angiosarcoma 70
RET and RAS Mutations in Medullary Thyroid Carcinoma (MTC) and Their Impact on Histologic Grade, Tumor Characteristics, and Clinical Outcome: An International Multicentric Study of 289 Patients 68
Molecular Classification of Endometrial Carcinoma and Immune Phenotypes: an Integrated Approach to Improve Risk Stratification 62
Hepatocellular Carcinomas with Concomitant Mutations of TERT, TP53, and CTNNB1: Is There a Role for Artificial Intelligence? 61
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region 61
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC 57
Ovarian mixed malignant Brenner-mucinous tumour: report of a unique case 55
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 53
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 51
Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma 50
High-grade Endometrial Endometrioid Carcinoma: A Case Report of Complete Transdifferentiation to Pilomatrix-like Carcinoma 44
NRAS-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment 44
Late Recurrence of a Growing Teratoma Syndrome-Like Lesion in a 54-Year-Old Female Patient: A Follow-up Case Report 33
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792] (Critical Reviews in Oncology / Hematology (2025) 213, (S1040842825001805), (10.1016/j.critrevonc.2025.104792)) 15
Totale 7.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 32 4 0 5 6 0 2
2021/2022121 0 0 1 2 15 10 1 3 11 14 46 18
2022/2023662 18 28 17 42 63 44 21 54 144 49 83 99
2023/2024531 76 37 36 46 61 64 23 41 26 27 32 62
2024/20252.114 126 134 159 104 151 101 147 94 70 203 310 515
2025/20263.595 1.151 848 552 530 408 106 0 0 0 0 0 0
Totale 7.072